Table 2.
CMV− | CMV+ | |
---|---|---|
Cardiovascular intervention | 9.2% (n = 11) | 12.7% (n = 21) |
Myocardial infarction | 3.4% (n = 4) | 9.1% (n = 15) |
Stroke | 1.7% (n = 2) | 1.8% (n = 3) |
Total | ||
Any cardiovascular disease | 14.3% (n = 17) | 23.6% (n = 39) |
Serostatus is serostatus at study endpoint. Cardiovascular intervention: participant undergone either bypass surgery, cardiac valve dilation surgery, cardiac catheterisation, pacemaker placement, or peripheral vascular surgery.